Old Web
English
Sign In
Acemap
>
Paper
>
patients with {beta}-thalassemia A Phase III study of deferasirox (ICL670), a once-daily oral iron chelator, in
patients with {beta}-thalassemia A Phase III study of deferasirox (ICL670), a once-daily oral iron chelator, in
2010
Daniele Alberti
Nancy F. Olivieri
Isabelle Thuret
Bertram Opitz
Catherine Ressayre-Djaffer
Peter L. Marks
Patricia J. Giardina
A. Kourakli-Symeonidis
Gritta E. Janka-Schaub
Thomas D. Coates
Guillermo Drelichman
Carmelo Magnano
Monica Verissimo
Miranda Athanassiou-Metaxa
Antonis Kattamis
Yurdanur Kilinc
John Porter
Marcello Capra
Renzo Galanello
Maria Domenica Cappellini
Alan Cohen
Antonio Piga
Mohamed Bejaoui
Silverio Perrotta
Leyla Agaoglu
Keywords:
Gastroenterology
Beta thalassemia
Deferasirox
Internal medicine
Medicine
Iron Chelator
Correction
Cite
Save
Machine Reading By IdeaReader
22
References
0
Citations
NaN
KQI
[]